PTP1B Inhibitors (Dalian University Of Technology/Second Military Medical University PLA/North China Pharmaceutical Group Corp (NCPC))

N/A

Report date: 2025/01/26 18:38:40
NME

Base Information

Drug NamePTP1B Inhibitors (Dalian University Of Technology/Second Military Medical University PLA/North China Pharmaceutical Group Corp (NCPC))
Drug Alias Nametrivaric acid
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-tyrosine phosphatase 1B inhibitors
TargetsProtein-tyrosine phosphatase 1B
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesDalian University Of Technology
China Registration ClassN/A

Develop Information

Active CompaniesDalian University Of TechnologySecond Military Medical University Of Chinese People'S Liberation ArmyNorth China Pharmaceutical Company Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A